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Abstract  
Objective: To investigate the volumetric correlates of speech in Amyotrophic Lateral Sclerosis 
(ALS). 
Methods: Twenty-three ALS patients had a structural 3D MRI scan, neuropsychological, linguistic 
and speech assessments.  Twenty-three healthy adults of comparable age, education, white-matter 
hyperintensities and intracranial volumes were also recruited.  Between-group differences in grey 
matter and white matter (WM) were examined to characterise ALS patients accurately.  The 
association between residual speech and volumetric maps was studied in these patients. 
Results: ALS patients showed a pattern of WM reduction, which was located in peri-cortical 
motor/premotor fibres bilaterally, and in a large volume extending from the pons/midbrain to the 
cerebellum.  A speech composite score was computed, and this was positively associated with 
premotor/supplementary-motor WM bilaterally, right cerebellar WM, and the posterior-caudal 
cerebellar cortex, bilaterally. 
Conclusion: Variance in residual speech in ALS is associated with variance in premotor WM and 
cerebellar volumes.  Since premotor associations were found in volumes where ALS patients 
showed WM reduction, this region is believed to be directly involved in speech execution in this 
group.  Since cerebellar associations were instead found in volumes free from shrinkage, this region 
is interpreted as playing a modulatory role, compensating for the impact of ALS pathology. 
 
Keywords: 
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3 
 
Introduction 
Amyotrophic Lateral Sclerosis (ALS) disrupts structure and function of motor and non-motor neural 
pathways (1-2), often triggering cognitive (mostly executive and linguistic) decline (3-4).  Deficits 
in language appear to be independent from any concurrent dysexecutive symptom (5), and, at least 
in the sub-population with a C9Orf72 mutation, there is evidence of volumetric loss and cortical 
WKLQQLQJRIWKHRSHUFXODUSRUWLRQRI%URFD¶VDUHD2QWKH other hand, the association between 
$/6¶VQHXUDOGLVUXStion and peripheral aspects of linguistic processing has been a largely 
unexplored research territory.  Impaired speech (dysarthria) is a prominent feature of ALS.  This 
normally results from an interplay between diverse factors, such as respiration, phonation, vocal 
resonation and articulation (7).  Linguistic difficulties in ALS may be visible even before the onset 
of any dysarthric problem (8).  Although this indicates that any impairment in the central linguistic 
components is independent from peripheral aspects of verbal production, it has also been suggested 
that LPSRYHULVKPHQWRIODQJXDJHPLJKWLQSDUWUHIOHFWDQ³HFRQRP\-of-ZRUGLQJ´VWUDWHJ\LQYHUEDO
communication, adopted by patients in response to an increasingly difficult speech (9).  To be 
accomplished accurately, speech is a motor skill that requires precise coordination, and its various 
contributing factors are believed to be regulated at a neural level (10).  At present it is still not 
completely clear to what extent the factors playing a role in dysarthria are related to the 
neurodegeneration triggered by ALS.  In fact, there are studies which found positive associations 
between the bulbar sub-score of the revised version of the Amyotrophic Lateral Sclerosis 
Functional Rating Scale (ALSFRS-R), and the anatomy of the lateral portion of the motor 
homunculus (11-12).  Although this sub-score estimates bulbar function, it incorporates different 
abilities in one single composite score, in which the assessment of speech is simply quantified with 
a number ranging from 0 to 4 (13). 
This study aimed to explore the structural correlates of speech in ALS more accurately.  The 
association between a proxy derived from clinical assessment of pneumo-phono-articulatory 
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capacities and regional maps of brain grey-matter (GM) and white-matter (WM) volumes was 
investigated in a sample of ALS patients experiencing various stages of dysarthric impairment. 
 
 
Material and methods 
Participants 
Thirty-one consecutive in-patients diagnosed with probable/possible ALS (all taking Riluzole 
medication) were enrolled.  Diagnoses were made independently by two neurologists, following 
established criteria (14), and a complete neurological examination was carried out on all patients.  
Exclusion criteria were set as follows: cerebrovascular disease, hypertension, diabetes, dyspnea, 
history of head injury or cardiac attacks, prescription of psychoactive medications. The ALSFRS-R 
scale was administered to evaluate disease severity (13), flanked by the Functional Independence 
Measure (FIM), to obtain a more detailed picture of functional deterioration (15).  No patient relied 
on artificial devices to support respiration.  Registration of onset type (spinal/bulbar) and disease 
duration served for a better characterisation of each participant.  A neuropsychological assessment 
was carried out to typify the SDWLHQWV¶overall cognitive profile.  The Mini-Mental State Examination 
(MMSE), the Raven Progressive Matrices and the Verbal Fluency tasks were used as proxies of 
overall cognitive abilities, based on their wide use in research on neurodegenerative diseases, and 
their susceptibility to difficulties in high-order cognitive functions such as abstract reasoning, 
semantic access and executive management of retrieval (16-18).  These tests were included in the 
procedure to provide a comprehensive description of the sample of patients.  The Aachen Aphasie 
Test (AAT) was administered to assess language skills (19), together with a measurement of 
phonetic inventory, i.e. the ability to produce the sounds of the Italian language in their various 
interword positions (20).  One patient was excluded because of severe cognitive impairment in 
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comprehension which made speech assessment not possible.  Ethical approval was received from 
the IRCCS Institutional Review Board (Venice, Italy) and following ethical standards as set in the 
Helsinki Declaration on human experimentation.  Informed written consent was obtained from all 
participants. 
 
Assessment of dysarthric symptoms 
Although physiological, kinematic, and acoustic techniques have been designed to measure the 
physical properties of speech production, clinical assessment of dysarthria in ALS patients is mainly 
based on the evaluation of perceptual and functional properties of speech.  The methodology 
included in this study reflects routines used in a clinical setting.  Pneumo-phono-articulatory 
features of ALS SDWLHQWV¶YHUEDOSURGXFWLRQZHUHDVVHVVHGXVLQJVXEWHVWVDQGIURPWKH,WDOLDQ
YHUVLRQRIWKH5REHUWVRQ¶V3URILOH7HVWRIG\VDUWKULD (21), adapted by Fussi and Cantagallo (22).  
These were a quantitative evaluation of maximal Expiratory Duration Rate (EDR), maximal 
Phonatory Duration Rate (PDR) and Diadochokinetic Rate (DKR).  EDR and PDR consisted in the 
DELOLW\WRVXVWDLQDSURORQJHG³V´DQG³D´VRXQGUHVSHFWLYHO\('5KDVEHHQDOUHDG\XVHGDVDQ
indicator of the aerodynamic area of vocal production in previous research (23), while PDR is 
normally used in clinical practice as a measure to estimate phonatory competence (24).  DKR 
identifies, instead, the ability to repeat sequences of sounds rapidly, and is a test often used in 
neurological settings to assess articulatory skills (25).  The score indicates the correct sound 
VHTXHQFHVRUDOO\JHQHUDWHGLQVIRUHDFKLWHPLWHPV³X-L´³SD´³WD´³ND´³NDOD´³SWN´, 
and the six performance scores were averaged.  One patient could not be examined because their 
health conditions deteriorated before speech assessment could be performed, and they were, 
therefore, excluded from the study, giving a sample size of 29 ALS participants. 
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MRI procedure 
All remaining patients were invited to have a brain-scan protocol.  Three-dimensional T1-weighted 
structural scans were acquired on a 1.5T Philips Achieva scanner with a Turbo Field-Echo 
Sequence, as part of a comprehensive scanning protocol.  Acquisition parameters were as follows: 
voxel dimension: 1.1x1.1x0.6mm; FOV: 250mm; matrix size 256x256x124; TR: 7.4ms, TE: 3.4ms; 
flip angle: 8°.  T2-weighted and FLAIR-weighted scans were also acquired to allow the evaluation 
of vascular load and the detection of contingent abnormalities.  The scanning procedure could not 
be completed in six patients because of medical incompatibility with the MRI environment, or lack 
of compliance.  Twenty-three ALS patients were thus included in the final analyses.  Twenty-three 
healthy controls (as previously determined by full neuropsychological examination and history), 
individually matched as closely as possible to the ALS patients for gender, age, and education level 
were included in the scanning sessions.  The inclusion of a control group served to characterise the 
extent of neural damage in ALS patients. 
 
Data analysis 
MRI images were preprocessed with Matlab 7 and Voxel-Based Morphometry (VBM), 
implemented in the Statistical Parametric Mapping (SPM) 8 software (Wellcome Trust Centre for 
Neuroimaging, London, UK) (26).  This procedure included tissue-class segmentation, spatial 
transformation to a template, and spatial smoothing, carried out with an 8mm Full-Width at Half 
Maximum gaussian kernel. 
Global native-space volumes of GM, WM, and cerebrospinal fluid were extracted from all scans to 
compute total intracranial volume and tissue ratios (RatioGM , RatioWM,  and RatioGM-PLUS-WM).  
FLAIR-weighted images were examined, and a scale from 0 to 3 was used in the quantification of 
periventricular and deep-WM hyperintensities (27).  The presence of cortical hyperintensities, 
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basal-ganglia lesions and cerebral infarcts was also assessed.  In the case of one ALS patient, this 
procedure was carried out on the T2-weighted scan, as no FLAIR scan was available.  Numeric 
variables were analysed with the IBM SPSS 21 software.  Demographics were analysed with 
Independent-Sample t tests or Chi-square tests.  Between-group differences in total-brain volumes 
and ratios were analysed with both Independent-Sample t tests and ANOVAs, correcting for age and 
education level.  Since the quantification of WM lesional burden had limited parametric properties, 
between-group differences were analysed with a Mann-Whitney U test.  3HDUVRQ¶VU correlations 
were run between total-brain volumes/ratios and speech parameters. 
All remaining analyses were run with SPM.  Independent-Sample t tests were carried out to 
compute group-dependent regional differences, correcting for age, education level and RatioGM-PLUS-
WM.  The association between speech and brain volumes was instead analysed with Multiple-
Regression Basic Models, in which the composite index was analysed in association with GM and 
WM maps, independently and the ALSFRS-R score and the RatioGM-PLUS-WM were added as 
nuisance regressors. 
A significant p<0.001 value (uncorrected) was selected, and the cluster extent was set at 50 
contiguous voxels.  A cluster-level pFWE<0.05 was then chosen as threshold of significance.  
Given the exploratory nature of the study, the uncorrected findings of the regression models were 
also examined.  Significant MNI-space peak coordinates were converted into Talairach space using 
a non-linear transform (imaging.mrc-cbu.cam.ac.uk/downloads/MNI2tal/mni2tal-m) and interpreted 
using the Daemon client (28-29). 
 
 
Results 
Sample characterisation 
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All variables are reported in Table 1.  The score of the distinct ALSFRS-R subsections was 
consistent with onset type.  One patient refused any neuropsychological assessment, but no overt 
cognitive impairment had been noticed in their initial neurological examination.  Overall, cognitive 
profiles were incomplete, but were equally considered anyway for qualitative description.  MMSE 
scores could be collected for 14 of the remaining 22 ALS patients, and these ranged between 24 and 
30, suggesting absence of major cognitive impairment.  Only two patients performed below cut-off 
on the Raven Progressive Matrices test.  The Verbal Fluency tests were available for 19 patients.  
Although ALS patients performed significantly worse than healthy controls on the Category 
Fluency test (the sole test showing between-group differences), no individual score fell below cut-
off.  One patient performed below cut-off in the Letter Fluency test.  Based on this evidence and on 
further clinical considerations it was concluded that, for the majority of patients, cognitive skills 
were, on average, only very mildly impaired.  The AAT was available for 21 patients, and these 
scores were compared with the clinical cut-offs which quantify specific levels of severity (19).  
Three SDWLHQWVKDGDPRGHUDWHGHILFLWLQ³&RPSUHKHQVLRQ´ZKHUHDVWZRother patients had a 
PRGHUDWHGHILFLWLQ³5HSHWLWLRQ´DQG³1DPLQJ´.  The remaining scores were either normal or in the 
mildly-impaired range.  7KLVZDVDOVRYDOLGIRUQLQHSDWLHQWVZKRGLGQRWFRPSOHWHWKH³:ULWWHQ
/DQJXDJH´VXE-test in its entirety (their partial scores were compared with the available normative 
sub-scores).  The phonetic inventory was administered to 18 patients, nine of whom did not obtain a 
full score.  In sum, language was mildly affected in ALS patients, both in its receptive and 
productive components, while phonetics was more substantially impaired. 
Individual measurements of speech were compared with reference scores (22).  Based on this 
classification, 15 patients showed impaired performance in all subtests.  Of the remaining eight 
patients, normal EDR, PDR, and DKR sub-scores were achieved by three, six and one patient, 
respectively, with two patients showing both retained EDR and PDR. 
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The amount of periventricular and deep-WM lesions did not differ between groups (p=0.597 and 
p=0.419, respectively).  One ALS patient had a single basal ganglionic lesion, whereas three ALS 
patients had evidence of past cerebral infarcts. 
ALS patients had significantly less WM (t44=-2.776, p=0.008), lower RatioWM (t44=-3.563, p=0.001) 
and lower RatioGM-PLUS-WM (t44=-2.386, p=0.021).  These findings were confirmed after controlling 
for age and education (F1,42=8.372, p=0.006; F1,42=19.086, p<0.001; F1,42=8.873, p=0.005, 
respectively).  There were no differences in total intracranial volume, total GM, RatioGM and, in 
addition, no difference in regional GM was found.  On the other hand, ALS patients had a vast 
reduction in two separate sections of corticospinal WM: an upper symmetric reduction extending 
from the corona radiata to the semioval centres of the motor and premotor/supplementary-motor 
cortices, and a lower midline reduction in pontine/mesencephalic and cerebellar WM (Table 2; 
Fig.1). There were no areas in which GM or WM volume was larger in the ALS patient group. 
 
 
Association between brain morphology and residual pneumo-phono-articulatory capacity 
The three speech measures were normally distributed (as indicated by Kolmogorov-Smirnov Tests¶V
p>0.05), were mutually correlated, and were associated with disease severity.  EDR and DKR were 
also correlated with functional independence.  Both total WM volume and RatioWM correlated with 
EDR and PDR but not with DKR.  Aside from the mutual correlations, all r scores indicated 
moderate associations.  GM measures and disease duration were not correlated with any variable 
(Table 3).  To enhance statistical robustness in the correlational analyses (by circumventing the 
need for correction for multiple comparisons), standardised residuals of EDR, PDR and DKR were 
calculated and averaged.  This average speech composite score characterised the general level of 
speech production of each patient. 
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All associations between pneumo-phono-articulatory scores and regional volumetric maps are 
reported in Table 4 and illustrated in Fig.2.  None of these survived a cluster-level pFWE<0.05 but 
all peaks did survive a less robust small-volume corrected pFWE<0.05. 
Speech composite scores were positively associated with a bilateral and symmetric pattern of GM 
volume located in the posterior and caudal section of the cerebellar cortex.  Additionally, significant 
associations were found in a WM cluster in the right cerebellar hemisphere, and, bilaterally, in WM 
sections adjacent to both dorsal and ventral parts of Brodmann Area 6.  These latter 
premotor/supplementary-motor volumes were almost entirely contained in the set of voxels were 
decreased WM density had been seen.  No negative associations were found. 
 
 
Discussion 
The association between pneumo-phono-articulatory skills and GM/WM volumes in ALS was 
investigated.  Clinical measures of speech were selected based on their easy measurability in a 
hospital setting.  For the purpose of sample characterisation, regional GM and WM volumetric 
maps of ALS patients were compared statistically with a group of healthy adults matched for age 
and education, and having a comparable load of WM hyperintensities. 
The group comparison revealed no GM difference between groups.  The pattern of GM volumetric 
alterations observed in ALS has been so far inconsistent (1-2, 30).  A cross-sectional meta-analysis 
identified a sole small significant cluster of GM loss in ALS patients, located in the right precentral 
gyrus (31), while parallel studies found no precentral reductions (32-33), no volumetric loss in GM 
at all (34), or mixed pattern of motor and extra-motor GM volumetric decrease (11).  On the other 
hand, less WM volume was found in ALS patients in the corticospinal tract including midbrain, 
pons and semioval motor/premotor fibres), and in the cerebellum. Notably, this reduction even 
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survived complete Family-Wise correction.  The literature of reference here is even more 
heterogeneous, as a number of volumetric studies found no cross-sectional differences in WM 
between patients and healthy controls (e.g. 33, 35), while other studies reported WM decrease (36-
37) or even increase (32, 38).  As described in a recent review, ALS is a disease characterised by a 
remarkable level of clinical heterogeneity (39).  In the attempt to maintain a specific focus on brain 
volumetric measures, a series of possible reasons might account for these inter-study discrepancies.  
Agosta and colleagues commented over the possible impact of gliosis which, activating in response 
WRQHXUDOGDPDJHWUDQVODWHVDFWXDOO\LQWRD*0LQFUHDVHDQG³PD\RFFXUDWDGHJUHHHQRXJKWR
³PDVN´WLVVXHORVV´SDJH,QDVLPLODUIDVKLRQ.DVVXEHNDQGFROOHDJXHVGHVFULEHG
volumetric increase in the capsular and periventricular section of corticospinal WM of ALS 
patients, and interpreted this piece of evidence as due to the presence of hyperintensities associated 
with the disease, which might get somehow misconstrued by the neuroimaging software (38).  In 
addition to these two biological mechanisms, other, methodological factors contribute to the 
variability of findings.  These include generally small and heterogeneous samples, and divergences 
in methodological aspects (30, 41).  There is also evidence that genetic and sporadic ALS differ in 
their volumetric signature (6), and this too may be of relevance when samples are of variable 
aetiology. 
Despite no p value survived a cluster-level FWE correction, a set of uncorrected findings 
(interpreted thus following a more liberal approach) indicated that retained speech associates more 
with WM than GM volumetric measures.  This is consistent with a study in which patients affected 
by progressive spastic dysarthria (of various aetiology) had exclusively WM (and no GM) loss (42).  
On this note, the pattern of association between residual speech abilities and regional GM observed 
in the cerebellum might have been partially artefactual, possibly driven by an inaccurate process of 
skull-stripping in the region where the caudal part of the cerebellar hemisphere and the bone tissue 
of posterior cranial fossa are in anatomical contiguity. 
12 
 
The overall pattern of association extended to areas involved in motor planning, preparation and 
execution, including premotor, supplementary-motor, and cerebellar volumes.  No association 
emerged in the lateral portion of the motor homunculus as found in previous studies in which 
speech abilities were assessed as part of the ALSFRS-R bulbar sub-score. (11-12), or in any portion 
of the primary motor cortex.  In our sample, the correlation between speech composite scores and 
ALSFRS-R bulbar sub-scores was significant (p<0.014), but only moderate in strength (r=0.505).  
Since the construct validity of the composite score supersedes that of the ALSFRS-R sub-score as a 
proxy of speech, it is suggested that the primary motor cortex might not be primarily involved in the 
neural control of speech in ALS. 
Motor/premotor areas, cerebellum, insula, left operculum and basal ganglia are all reputed to concur 
in the neural control of verbal execution in the healthy nervous system (10). We found that 
variability in residual speech was positively associated with volumetric variability of two of the 
aforementioned regions. The premotor cortex was recently described as a structure playing a 
compensatory role in sustaining normal speech after acute damage of left putaminal-capsular areas 
(43).  With regard to this study, premotor/supplementary-motor associations were largely located in 
those regions where a between-JURXSORVVRIYROXPHKDGEHHQREVHUYHG7KLV³SDWKRORJLFDO
variance in VWUXFWXUH´-³ORVVRIIXQFWLRQ´UHODWLRQVXJJHVWVWKDWWKHUROHRISremotor areas might be a 
direct involvement of these areas in speech execution.  The cerebellum is instead normally 
considered responsible for creating fine-grained motor models exploited by motor areas to 
accomplish speech movements (10).  Cerebellar activations are visible during tongue and lip 
movements, and ischemic lesions involving these regions provoke dysarthric symptoms (44).  With 
regard to this study, associations were found in cerebellar regions in which no single voxel of 
volumetric loss had emHUJHG7KLV³QRQ-pathological variance in VWUXFWXUH´-³ORVVRIIXQFWLRQ´
relation suggests that the cerebellum might act as modulator, rather than a structure involved in the 
³IURQWOLQH´RIVSHHFKH[HFXWLRQ,QIDFWZKLOVW$/6GLVUXSWVFRUWLFDOQHWZRUNV the nervous system 
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tries to compensate by inducing parallel increases in connectivity (45).  Albeit being based on 
volumetric evidence, what we observed in this study might have been the outcome of a similar 
process: circuital disruption involving the set of areas responsible for speech execution, and 
compensatory involvement of additional, modulatory regions.  This entire pattern, however, has to 
be interpreted with caution, as no finding actually survived a cluster-level FWE correction. 
 
 
Limitations 
Albeit being based on a sample of comparable size as in other publications (46-47), this study was 
not sufficiently powered to examine the impact of onset type and onset side, both potentially 
influential in these analyses.  Moreover, the rate of disease progression was not measured.  There is 
evidence that this parameter may influence structural properties of WM (47).  Additionally, the 
pattern of association between speech and WM was captured by VBM, which measures 
macroscopic WM properties, and does not proYLGHDQ\LQIRUPDWLRQDERXWILEUHV¶LQWHJULW\
Although DTI is more sensitive than VBM to WM alterations (48), however, it is also extremely 
more susceptible to the impact of unspecific short-term stimulation and the possible effect of speech 
therapy (see 49-50 for a proof of concept).  On the other hand, the properties of WM calculated by 
VBM are more stable, and for this reason the two techniques are methodologically complementary 
in nature. 
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Conclusion 
Pneumo-phono-articulatory aspects of speech were associated with premotor/supplementary-motor 
and cerebellar brain volumes.  These represented regions believed to support the neural control of 
speech in healthy adults (10), and are suggested to serve a similar role in ALS. Uncorrected findings 
suggest that premotor areas might be directly involved in speech production, while cerebellar 
regions might serve a modulatory role and appear to be recruited to compensate for the neural de-
regulation triggered by ALS in motor/premotor regions. 
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Table 1:  Characterisation of participants, and neuropsychological and speech scores 
 ALS Patients n Healthy Adults n p 
Age (years) 62.70 (11.54) 23 61.91 (13.12) 23 0.83 
Education (years) 8.17 (3.72) 23 8.35 (3.77) 23 0.87 
Gender (F/M) 10/13 23 10/13 23 1.00 
Handedness (left/right) 5/18 23 3/20 23 0.44 
MMSE 27.50 (1.99) 14 28.39 (2.04) 23 0.20 
Raven Matrices 27.82 (6.57) 22 29.70 (5.39) 23 0.30 
Phonemic Fluency 25.53 (9.06) 19 31.57 (12.04) 23 0.07 
Semantic Fluency 33.89 (8.39) 19 39.43 (7.72) 23 0.03* 
Onset Type (spinal/bulbar) 20/3 23  
Disease Duration (months) 39.26 (12.93) 23  
 
  Cut-off / Reference score 
ALSFRS-R 31.39 (5.33) 23 § 
ALSFRS-R (Bulbar Subscore) 9.39 (1.67) 23 § 
FIM 68 (14.37) 23  
AAT: Token Test 3.71 (4.11) 21  
AAT: Repetition 141.30 (8.00) 20  
AAT: Written Language 65.00 (25.64) 21  
AAT: Naming 111.25 (8.53) 20  
AAT: Comprehension 108 (7.65) 21  
Phonetic Inventory 25.33 (3.97) 18 § 
EDR 11.39 (6.73) 23 V 
PDR 12.83 (6.79) 23 V 
DKR 10.06 (4.16) 23  
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Mean raw scores are reported, and standard deviation are included in parentheses. Between-group 
statistical comparisons were carried out with Independent-Sample t tests (for age, educational 
levels, and neuropsychological indices), or 3HDUVRQ¶V&KL-square tests (for gender and handedness).   
The ALSFRS-R reference values indicate full scores, which would be expected in those without 
IXQFWLRQDOGHILFLWV$),0LVLQGLFated by the regional legislation of reference as a cut-off score 
to entitle patients to be admitted to neurorehabilitative health-care hospitalisation. AAT and speech 
cut-off scores were indicated in their respective publication. 
MMSE: Mini-Mental State Examination; ALSFRS-R: Amyotrophic Lateral Sclerosis Functional 
Rating Scale ± Revised; FIM: Functional Independence Measure; AAT: Aachen Aphasie Test; 
('5([SLUDWRU\'XUDWLRQ5DWH3'53KRQDWRU\'XUDWLRQ5DWH'.5'LDGRFKRNLQHWLF5DWH³´
indicates p<0.05. 
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Table 2 Between-group differences in regional white matter 
Cluster 
Number Brain Area Side 
Cluster 
Size 
(voxels) 
Cluster 
Level 
DFWE corr 
Z Score at 
Local 
Maximum 
Talairach 
Coordinates 
x y z 
1 Precentral Gyrus R 1320 <0.001 5.62 34 -11 52 
 
Medial Frontal Gyrus R   4.64 8 -18 58 
 
Precentral Gyrus R   4.55 44 -15 45 
2 Pons L 1831 <0.001 5.46 -16 -26 -22 
 
Cerebellar Culmen R   4.17 24 -36 -25 
 
Midbrain R   4.01 14 -18 -18 
3 Medial Frontal Gyrus L 1345 <0.001 5.16 -8 -22 60 
 
Precentral Gyrus L   4.92 -32 -13 54 
 
Precentral Gyrus L   4.84 -32 -21 51 
 
        
 
Peak coordinates are reported. L: Left; R: Right; FWE: Family-Wise Error. 
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Table 3 Correlation between speech parameters, clinical variables, and global brain volumes 
 EDR PDR DKR Disease Duration 
ALSFRS-
R FIM 
Total 
GM 
Total 
WM 
Total 
Intracranial 
Volume 
Ratio
GM 
Ratio
WM 
RatioGM-
PLUS-WM 
EDR 
Pearson's r 1 
  
-0.318 0.489 0.476 0.080 0.417 0.175 -0.087 0.435 0.218 
p 
   
0.140 0.018 0.022 0.716 0.048 0.424 0.693 0.038 0.318 
PDR 
Pearson's r 0.749 1  -0.346 0.472 0.408 0.215 0.477 0.293 -0.057 0.426 0.237 
p <0.001   0.106 0.023 0.053 0.325 0.021 0.175 0.798 0.043 0.277 
DKR 
Pearson's r 0.728 0.504 1 -0.139 0.419 0.459 -0.008 0.109 -0.021 -0.006 0.153 0.097 
p <0.001 0.014  0.529 0.047 0.028 0.969 0.619 0.923 0.979 0.485 0.660 
Composite 
Score 
Pearson's r 0.939 0.854 0.846 -0.304 0.523 0.509 0.109 0.380 0.169 -0.057 0.384 0.209 
p <0.001 <0.001 <0.001 0.159 0.010 0.013 0.622 0.073 0.440 0.797 0.070 0.338 
 
Significant correlations and p values are indicated in bold. EDR: Expiratory Duration Rate; PDR: Phonatory Duration Rate; DKR: Diadochokinetic 
Rate; ALSFRS-R: Amyotrophic Lateral Sclerosis Functional Rating Scale ± Revised; FIM: Functional Independence Measure; GM: Grey Matter; 
WM: White Matter. 
24 
 
 
Peak coordinates are reported. L: Left; R: Right; GM: Grey Matter; WM: White Matter; FWE: 
Family-Wise Error. 
 
 
 
 
Table 4 Positive associations between pneumo-phono-articulatory composite score and brain volumes in ALS patients 
Cluster 
Number Brain Area Side 
Cluster 
Size 
(voxels) 
Cluster 
Level 
DFWE corr 
Z Score at 
Local 
Maximum 
Talairach 
Coordinates 
x y z 
GM 
1 Cerebellar Inferior Semi-Lunar Lobule L 93 0.446 4.52 -12 -72 -38 
2 Cerebellar Inferior Semi-Lunar Lobule R 59 0.713 3.70 10 -72 -35 
WM 
1 Frontal Sub-Gyral R 191 0.102 4.39 22 -13 54 
 
Precentral Gyrus R   3.80 38 -2 35 
 
Precentral Gyrus R   3.38 34 -9 48 
2 Frontal Sub-Gyral L 109 0.258 4.09 -30 -8 41 
 
Precentral Gyrus L   3.76 -36 -2 41 
3 Frontal Sub-Gyral L 99 0.290 3.85 -14 -23 45 
 
Frontal Sub-Gyral L   3.62 -14 -15 43 
4 Cerebellar Tonsil R 136 0.188 3.58 22 -68 -32 
 
Cerebellar Tonsil R   3.28 26 -48 -31 
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Figure legends 
 
Figure 1.  
WM areas in which ALS patients showed lower volumetric values in comparison with the group of 
healthy controls. Slice coordinates in MNI space are as follows: upper row, y = -39, y = -31, y = -
23; lower row, y = -15, y = -7, y = +1. 
 
Figure 2. 
Associations between regional WM volumes and performance in the tests measuring speech as 
indicated by the speech composite score. Z coordinates in MNI space are as follows: upper row, x = 
-30, x = +39; lower row, y = -17, y = -8, z = -40. 
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